```html

Zygotic Bleeding (Post‑partum Hemorrhage)

What is Zygotic Bleeding (Post‑partum Hemorrhage)?

Post‑partum hemorrhage (PPH) is excessive bleeding that occurs after the birth of a baby. When the bleeding originates from the placental site or the uterine lining where the embryo (zygote) implanted, it is sometimes described in the literature as zygote‑related bleeding. In clinical practice the term “zygotic bleeding” is not widely used; the condition is classified under PPH, which remains one of the leading causes of maternal mortality worldwide <sup>[1][2]</sup>.

The World Health Organization defines PPH as a loss of ≥500 mL of blood after a vaginal delivery or ≥1000 mL after a cesarean delivery, or any amount of bleeding that causes hemodynamic instability. The “zygotic” descriptor simply emphasizes that the bleeding starts at the site where the fertilized egg originally attached to the uterine wall. Understanding this helps clinicians target the underlying cause—whether it is uterine atony, retained placental tissue, or trauma to the birth canal.

Common Causes

The following conditions account for the majority of post‑partum hemorrhage cases, including those that involve bleeding from the original implantation site:

• Uterine atony – Failure of the uterus to contract effectively after delivery.
• Retained placental tissue – Fragments of placenta or membranes remain attached, preventing proper contraction.
• Uterine inversion – Rare but severe turning inside‑out of the uterus during delivery.
• Genital tract lacerations – Tears of the cervix, vagina, or perineum.
• Uterine rupture – A tear through the uterine wall, more common after a prior cesarean.
• Coagulopathy – Blood clotting disorders such as disseminated intravascular coagulation (DIC) or pre‑existing platelet abnormalities.
• Uterine arteriovenous malformations (AVM) – Abnormal vascular connections that can bleed profusely.
• Placenta previa – Placenta covering the cervical os, often leading to heavy bleeding when the placenta separates.
• Placenta accreta spectrum – Abnormally deep attachment of the placenta into the myometrium, making separation difficult.
• Infection‑related uterine atony – Endometritis can impair uterine tone and increase bleeding.

Associated Symptoms

Women experiencing PPH may notice a combination of the following signs, often alongside the obvious vaginal bleeding:

• Sudden drop in blood pressure (felt as dizziness or faintness).
• Rapid heart rate (tachycardia) >100 beats/min.
• Pale, cool, or clammy skin.
• Feeling of weakness or exhaustion.
• Chest pain or shortness of breath.
• Decreased urine output (< 30 mL/hr).
• Swelling of the legs or abdomen due to fluid shifts.
• Persistent abdominal cramping (often a sign of uterine atony).

When to See a Doctor

Post‑partum bleeding that is heavier than a normal “lochia” (the usual postpartum discharge) should prompt immediate evaluation. Contact a health professional if you notice:

• Soaking a pad in 15 minutes or less (or > 1‑2 pads per hour).
• Bright red blood soaking through clothing.
• Clots larger than a golf ball.
• Any sudden dizziness, faintness, or feeling “light‑headed”.
• Chest pain, shortness of breath, or a racing heart.
• Fever > 100.4 °F (38 °C) accompanied by heavy bleeding (possible infection).

Even if bleeding appears modest but is accompanied by the above systemic signs, seek care right away. Early intervention dramatically reduces the risk of severe anemia, shock, and death.

Diagnosis

Evaluation of post‑partum hemorrhage is systematic and may involve the following steps:

1. Clinical assessment – Vital signs, amount of blood loss (visual estimation or calibrated drapes), uterine size and tone, and a focused exam for lacerations.
2. Laboratory studies
   • Complete blood count (CBC) – to assess hemoglobin/hematocrit and platelet count.
   • Coagulation panel (PT/INR, aPTT, fibrinogen) – to detect coagulopathies.
   • Type and screen – in preparation for possible transfusion.
3. Imaging
   • Transabdominal or transperineal ultrasound – identifies retained placental tissue, uterine inversion, or AVM.
   • CT angiography or MRI – reserved for persistent bleeding when vascular malformations are suspected.
4. Physical examination of the birth canal – visual and digital inspection to locate lacerations or tears.
5. Quantification of blood loss – Using calibrated under‑buttock drapes (e.g., the “BRASSS‑V” drape) provides a more accurate estimate than visual judgment alone.

Treatment Options

Management hinges on rapid control of bleeding, restoration of circulating volume, and correction of any underlying coagulopathy. Treatment can be divided into immediate (in‑hospital) measures and adjunctive home‑care after stabilization.

In‑hospital (Medical) Management

• Uterine massage – First‑line maneuver to stimulate uterine contraction.
• Uterotonic medications
  • Oxytocin (Pitocin) – Continuous IV infusion or IM bolus.
  • Methylergonovine (Methergine) – Contraindicated in hypertension.
  • Carboprost tromethamine (Hemabate) – Prostaglandin analog; avoid in asthma.
  • Misoprostol – Oral or rectal; useful where IV meds are unavailable.
• Tranexamic acid (TXA) – Reduces fibrinolysis; recommended within 3 hours of onset (WHO 2022).
• Fluid resuscitation – Crystalloids (e.g., lactated Ringer’s) and blood products as needed (packed RBCs, plasma, platelets).
• Repair of lacerations – Suturing of vaginal, cervical, or perineal tears.
• Removal of retained tissue – Manual extraction or electrocautery under ultrasound guidance.
• Uterine tamponade – Balloon catheters (e.g., Bakri balloon) placed intra‑uterinely to exert pressure.
• Interventional radiology – Uterine artery embolization (UAE) for refractory bleeding.
• Surgical options
  • Compression sutures (B‑Lynch) – For uterine atony when medical therapy fails.
  • Hysterectomy – Life‑saving when all other measures are exhausted.

Home Care After Stabilization

• Continue oral iron supplementation (e.g., ferrous sulfate 325 mg PO daily) to rebuild hemoglobin.
• Maintain adequate hydration (2–3 L water per day unless restricted).
• Monitor lochia: progression from bright red → pink → serous over 2–6 weeks is normal.
• Rest and avoid heavy lifting (> 10 lb) for the first 2 weeks.
• Follow up with your obstetrician or midwife within 1 week of discharge.
• Report any sudden increase in bleeding, fever, or worsening pain immediately.

Prevention Tips

While not all cases of PPH are preventable, several strategies can reduce risk:

• Antenatal care – Regular prenatal visits to identify placental abnormalities (previa, accreta) early.
• Optimize hemoglobin – Treat iron‑deficiency anemia before delivery.
• Active management of the third stage – Administration of oxytocin immediately after delivery of the baby, controlled cord traction, and uterine massage.
• Controlled delivery techniques – Avoid excessive traction on the umbilical cord; use gentle fundal pressure.
• Screen for coagulation disorders – Particularly in women with a history of bleeding disorders, liver disease, or anticoagulant use.
• Educate patients – Ensure new mothers understand what constitutes normal lochia versus concerning bleeding.
• Prepare for high‑risk deliveries – Have uterotonics, tranexamic acid, and blood products readily available in the delivery suite for patients with known risk factors.

Emergency Warning Signs

Key Take‑aways

• Post‑partum hemorrhage is a medical emergency; “zygotic bleeding” refers to bleeding that begins at the original implantation site.
• Uterine atony, retained placenta, and birth‑tract trauma are the most common causes.
• Prompt recognition of abnormal bleeding, vital‑sign changes, and timely treatment (uterotonics, fluids, possible surgery) save lives.
• Regular prenatal care and active management of the third stage of labor are the best preventive measures.
• Never hesitate to call emergency services if you notice rapid or heavy bleeding, dizziness, or loss of consciousness.

---

References:

1. Mayo Clinic. Postpartum hemorrhage. https://www.mayoclinic.org
2. World Health Organization. WHO recommendations for the prevention and treatment of postpartum hemorrhage. 2022.
3. American College of Obstetricians and Gynecologists. Practice Bulletin No. 183: Postpartum Hemorrhage. 2020.
4. Cleveland Clinic. Postpartum hemorrhage: Causes, symptoms, and treatment. https://my.clevelandclinic.org
5. National Institutes of Health. Tranexamic acid for postpartum hemorrhage (WOMAN trial). 2020.

```